Samodzielny Publiczny Zakład Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Łodzi
Łódź-Widzew, Polonia
Tratamiento y acceso
- Tratamientos ofrecidosesketamine (Spravato)
- Vía de accesoCubierto por un programa nacional
- Coste y cobertura (estado en el registro)Covered by NFZ (drug programme B.147)
- ReembolsoNFZ drug programme B.147 - leczenie chorych na depresję lekooporną Cómo funciona el reembolso en Europa →
- Teléfono+48 42 675 75 00
- Sitio webhttps://csk.umed.pl/
Sobre este proveedor
The Central Clinical Hospital of the Medical University of Łódź (Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi) is one of Poland's major university hospitals. Per NFZ data, its psychiatric service provides esketamine for treatment-resistant depression under the fully funded NFZ program B.147. The hospital's psychiatric campus at ul. Czechosłowacka 8/10 houses the adult Psychiatry Clinic, a Mental Health Centre with a coordination and reporting point, a dedicated psychiatric admissions unit, and a Child and Adolescent Psychiatry Clinic, alongside the hospital's broad multi-specialty and research activity.
Servicios y programas
- Psychiatry Clinic (Klinika Psychiatrii), ul. Czechosłowacka 8/10
- Mental Health Centre (Centrum Zdrowia Psychicznego) with coordination and reporting point
- Psychiatric admissions unit (Izba Przyjęć Klinik Psychiatrii), ul. Czechosłowacka 8/10
- Child and Adolescent Psychiatry Clinic
- NFZ drug program B.147 — esketamine for treatment-resistant depression (per NFZ data)
Preguntas frecuentes
How do I get into the esketamine program at CSK UM in Łódź?
You need a psychiatrist's referral. The B.147 criteria are: age 18-75, moderate or severe depression confirmed as treatment-resistant after at least two adequate antidepressant courses. Contact the psychiatric campus at ul. Czechosłowacka 8/10 via the hospital's exchange (42 675 75 00) or e-registration to arrange qualification.
Is esketamine treatment free here?
Yes. Under NFZ program B.147, the medicine, its administration and the required post-dose observation are fully covered for up to 34 weeks — there is no charge to the patient.
What is the waiting time?
Per NFZ data (as of June 2026), the first available date was 2026-07-01, with no patients waiting.
Verificación
- Licencia / registroNFZ B.147
- Fuentehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Última verificación